Brief: CytoTools: delay in approval of DermaPro in India
March 4 (Reuters) - CytoTools AG T5OG.DE :
* Delay in approval of DermaPro in India
* Approval of DermaPro in India is delayed due to required
dermatological and toxicological animal study
Source text for Eikon: ID:nEQ7Mvt4Ha
Further company coverage: T5OG.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))
Recent news on bioXXmed AG
See all newsBrief: CytoTools Announces Completion Of Capital Increase
Brief: CytoTools - Disputes Between CytoTools, DermaTools, Shareholders Ended
Brief: CytoTools Announces Retirement Of Two Members Of Management Board
Brief: CytoTools Sees Complete Change Of Management Board And Supervisory Board Possible
Lordstown Motors says hedge fund may buy up to $400 mln of its stock (updated)